January 2025 in “NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES” This study found that only 48% of the medicinal plant uses reported by people in Lithuania's Marijampole region align with European Medicines Agency guidelines, highlighting the need for further evaluation of ethnopharmacological practices.
June 2023 in “British journal of dermatology/British journal of dermatology, Supplement” This study observed that among UK alopecia areata patients seeking JAK inhibitor treatments before public funding, many sourced medication from abroad due to high costs, with variable response rates and significant reliance on social media for information on accessing treatments.
9 citations
,
November 2022 in “JAAD International” This study found that patients with alopecia areata face challenges like medical uncertainty and lack of information, highlighting the need for reliable and accessible treatment information that aligns with their preferences.
October 2022 in “International Journal of Dermatology” In this study, patients using the digitally enabled platform Keeps for male pattern hair loss treatment reported positive health outcomes, with 81% experiencing hair regrowth or ceasing hair loss after six months.
August 2024 in “International Journal of Health Science” This narrative review found that Telogen Effluvium significantly affects women in Brazil due to its psychological impact and limited access to treatment, exacerbated by economic and healthcare disparities.